Interleukin-10 Inhibits Intimal Hyperplasia After Angioplasty or Stent Implantation in Hypercholesterolemic Rabbits
- 29 February 2000
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 101 (8) , 908-916
- https://doi.org/10.1161/01.cir.101.8.908
Abstract
Background—Intimal hyperplasia after stent implantation is the main cause of in-stent restenosis. Activated monocytes play a key role in intimal growth. The anti-inflammatory cytokine interleukin-1...Keywords
This publication has 25 references indexed in Scilit:
- Interleukin-10 Inhibits Postinjury Tumor Necrosis Factor-Mediated Human Vascular Smooth Muscle ProliferationJournal of Surgical Research, 1998
- DOWN‐REGULATION OF FIBRINOGEN BIOSYNTHESIS BY IL‐4, IL‐10 AND IL‐13British Journal of Haematology, 1996
- Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.Journal of Clinical Investigation, 1996
- Interleukin‐10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblastsEuropean Journal of Immunology, 1995
- Interleukin‐10 inhibits endotoxin‐induced tissue factor mRNA production by human monocytesFEBS Letters, 1993
- Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophagesBiochemical and Biophysical Research Communications, 1992
- Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine modelJournal of the American College of Cardiology, 1992
- Macrophage deactivation by interleukin 10.The Journal of Experimental Medicine, 1991
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991
- Metabolism of very low density lipoproteins after cessation of cholesterol feeding in rabbits. A factor potentially contributing to the slow regression of atheromatous plaques.Journal of Clinical Investigation, 1986